Page last updated: 2024-10-18

dihydroxyphenylalanine and Adenoma Sebaceum

dihydroxyphenylalanine has been researched along with Adenoma Sebaceum in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Adenoma Sebaceum: Facial ANGIOFIBROMA in tuberous sclerosis

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jimbow, K1
Fitzpatrick, TB1
Szabo, G1
Hori, Y1
Roth, JC1
Epstein, CJ1

Other Studies

2 other studies available for dihydroxyphenylalanine and Adenoma Sebaceum

ArticleYear
Congenital circumscribed hypomelanosis: a characterization based on electron microscopic study of tuberous sclerosis, nevus depigmentosus, and piebaldism.
    The Journal of investigative dermatology, 1975, Volume: 64, Issue:1

    Topics: Adolescent; Adult; Albinism; Black People; Child; Child, Preschool; Dihydroxyphenylalanine; Female;

1975
Infantile spasms and hypopigmented macules. Early manifestations of tuberous sclerosis.
    Archives of neurology, 1971, Volume: 25, Issue:6

    Topics: Biopsy; Catechol Oxidase; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Histocytochemistr

1971